Technical Analysis for EVGN - Evogene

Grade Last Price % Change Price Change
F 0.70 -0.13% 0.00
EVGN closed down 0.13 percent on Wednesday, May 8, 2024, on 16 percent of normal volume.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Earnings Movers Other 0.00%
Gapped Up Strength 0.00%
Stochastic Reached Overbought Strength -0.13%
Earnings Movers Other -0.13%
Weak + Overbought Other -0.13%
Outside Day Range Expansion -0.13%
Gapped Up Strength -0.13%
Overbought Stochastic Strength -0.13%
NR7 Range Contraction -1.28%
Narrow Range Bar Range Contraction -1.28%

   Recent Intraday Alerts

Alert Time
Gap Up Closed about 20 hours ago
Fell Below Previous Day's Low about 20 hours ago
Down 1% about 20 hours ago
Reversed from Up about 20 hours ago
Gap Up Partially Closed about 21 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Evogene Description

Evogene Ltd., a plant genomics company, engages in the development of enhanced plant traits through the use of plant genomics. It primarily focuses on the development of food crops, including corn, soybean, cotton, canola, rice, and wheat, as well as castor for the production of biofuel. The company's technologies include ATHLETE for gene discovery; Gene2Product for enhancing trait efficacy and probability of successful development of biotechnology seed products; and EvoBreed for breeding enhancement. It holds granted or pending patents to approximately 3,000 novel genes. The company has collaboration agreements with Bayer CropScience; Biogemma; Centre de Cooperation Internationale en Recherche Agronomique pour le Development; DuPont; Monsanto Company; Rahan Meristem (1998) LTD; Rasi Seeds (P) Ltd.; Syngenta; Vilmorin; Viterra; and Zeraim Gedera for the development of various products and provision of plant enhancement solutions. Evogene Ltd. was founded in 1999 and is headquartered in Rehovot, Israel.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Genomics Wheat Crops Soybean Biofuel Cotton Canola Oil Rehovot Monsanto Seed Products

Is EVGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 1.44
52 Week Low 0.4502
Average Volume 103,316
200-Day Moving Average 0.74
50-Day Moving Average 0.77
20-Day Moving Average 0.68
10-Day Moving Average 0.69
Average True Range 0.04
RSI (14) 48.72
ADX 13.07
+DI 17.81
-DI 17.70
Chandelier Exit (Long, 3 ATRs) 0.72
Chandelier Exit (Short, 3 ATRs) 0.75
Upper Bollinger Bands 0.76
Lower Bollinger Band 0.61
Percent B (%b) 0.64
BandWidth 20.94
MACD Line -0.01
MACD Signal Line -0.02
MACD Histogram 0.0099
Fundamentals Value
Market Cap 35.61 Million
Num Shares 50.5 Million
EPS -0.47
Price-to-Earnings (P/E) Ratio -1.50
Price-to-Sales 6.69
Price-to-Book 2.07
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.74
Resistance 3 (R3) 0.74 0.73 0.74
Resistance 2 (R2) 0.73 0.72 0.73 0.74
Resistance 1 (R1) 0.72 0.72 0.71 0.72 0.73
Pivot Point 0.71 0.71 0.70 0.71 0.71
Support 1 (S1) 0.69 0.70 0.69 0.69 0.68
Support 2 (S2) 0.68 0.69 0.68 0.67
Support 3 (S3) 0.67 0.68 0.67
Support 4 (S4) 0.66